Lumida
/CLDX
⌘K
Celldex Therapeutics Inc

Celldex Therapeutics Inc

CLDX
$35.35USD-0.14%-0.05 today

MARKET CAP

2.8B

P/E (TTM)

FWD P/E

DAY RANGE

$34 – $36

52W RANGE

$20
$40

AI Summary

Stalk
StalkMedium

CLDX remains in Stage 2 advancing within an intact long-term uptrend but is undergoing a sharp corrective pullback after a terminal blow-off top. Medium-term bias stays bullish as price holds above the rising 50-DMA and overall HH/HL structure. Short-term timing is unfavorable, with price below the 9- and 21-EMAs and momentum down, so we will stalk a pullback into the 50-DMA support zone for absorption before re-engaging.

  • Phase 2: 71% complete response at week 76 in CSU.
  • Cash position: $408M funds clinical trials through 2025.
  • Negative profitability factors indicate poor return generation.
Full analysis →
Insider Trades20 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jan 2, 2026BuyCLDXSamuel Bates MartinSVP AND CFO4,817$10.38$2.8B-12.28%+79.24%$50.0K+5.54%Stalk
Dec 15, 2025BuyCLDXRonald PepinSR. VP & CBO19,333$5.47$2.8B-12.28%+79.24%$105.7K+130.09%Stalk
Dec 4, 2025SellCLDXFreddy A. JimenezSVP & GENERAL COUNSEL4,166$29.09$2.8B-12.28%+79.24%$121.2K-11.92%Stalk
Aug 13, 2025SellCLDXFreddy A. JimenezSVP & GENERAL COUNSEL771$24.77$2.8B-12.28%+79.24%$19.1K-1.08%Stalk
Nov 11, 2024BuyCLDXAnthony S MarucciPRESIDENT & CEO11,500$26.82$2.8B-12.28%+79.24%$308.4K+39.95%Stalk
Jun 14, 2024BuyCLDXSamuel Bates MartinSVP AND CFO37,341$21.78$2.8B-12.28%+79.24%$813.3K+1.85%Stalk
Jun 14, 2024SellCLDXElizabeth CrowleySR. VP & CPDO60,000$22.62$2.8B-12.28%+79.24%$1.4M+0.00%Stalk
Jun 11, 2024BuyCLDXDiane C. YoungSVP, CHIEF MEDICAL OFFICER15,000$2.71$2.8B-12.28%+79.24%$40.6K+709.22%Stalk
Jun 7, 2024SellCLDXElizabeth CrowleySR. VP & CPDO30,000$22.38$2.8B-12.28%+79.24%$671.3K+0.00%Stalk
Jun 7, 2024SellCLDXDiane C. YoungSVP, CHIEF MEDICAL OFFICER45,000$35.26$2.8B-12.28%+79.24%$1.6M-95.51%Stalk
Jun 5, 2024BuyCLDXFreddy A. JimenezSVP & GENERAL COUNSEL9,540$10.38$2.8B-12.28%+79.24%$99.0K+21.50%Stalk
Jun 3, 2024SellCLDXFreddy A. JimenezSVP & GENERAL COUNSEL16,012$21.99$2.8B-12.28%+79.24%$352.1K+0.00%Stalk
Jun 3, 2024BuyCLDXMargo Heath-ChiozziSVP OF REGULATORY AFFAIRS123,027$21.35$2.8B-12.28%+79.24%$2.6M+5.46%Stalk
Jun 3, 2024BuyCLDXRichard M. WrightSR. VP & CCO114,313$24.90$2.8B-12.28%+79.24%$2.8M+9.58%Stalk
May 30, 2024SellCLDXSarah CavanaughSVP OF CORP AFFAIRS & ADMIN.41,706$19.76$2.8B-12.28%+79.24%$824.3K+0.00%Stalk
May 30, 2024SellCLDXMargo Heath-ChiozziSVP OF REGULATORY AFFAIRS72,438$19.95$2.8B-12.28%+79.24%$1.4M-2.06%Stalk
May 30, 2024SellCLDXSamuel Bates MartinSVP AND CFO60,000$24.19$2.8B-12.28%+79.24%$1.5M-5.69%Stalk
May 30, 2024BuyCLDXElizabeth CrowleySR. VP & CPDO81,542$18.04$2.8B-12.28%+79.24%$1.5M+4.39%Stalk
Feb 13, 2024BuyCLDXFreddy A. JimenezSVP & GENERAL COUNSEL24,166$3.86$2.8B-12.28%+79.24%$93.2K+314.58%Stalk
Jan 2, 2024BuyCLDXSamuel Bates MartinSVP AND CFO10,750$2.78$2.8B-12.28%+79.24%$29.9K+44.10%Stalk